Direct-Acting Antiviral Therapy in Patients with Chronic Hepatitis C Shows Liver Fibrosis Regression on Three Noninvasive Tests: A Puerto Rican Cohort.
In most CHC patients, DAA therapy leads to liver fibrosis regression. Obesity may play an important role in the worsening of hepatic fibrosis or the absence of fibrosis regression.
Authors
- Bárbara Rosado-Carrión
- Paola López-Marte
- Bianca Goyco-Cortés
Institutions
- Ponce Health Sciences University (PR)
- University of Puerto Rico System (PR)
- VA Caribbean Healthcare System (PR)
Publication Details
- Journal
- PubMed
- Published
- 2024-09-01
- Primary Topic
- Hepatitis C virus research
- Type
- article
- Field-Weighted Citation Impact
- 0.00